Bladder Carcinoma Stage IV
1 clinical trials · Condition
◉ Watch Bladder Carcinoma Stage IV
| Record | Firm | Date |
|---|---|---|
| To Evaluate the Efficacy of NY-ESO-1-specific T Cell Receptor Affinity Enhancing Specific T Cell in Solid Tumors (NCT03159585) | Zhujiang Hospital | 2017-04-14 |
Track Bladder Carcinoma Stage IV automatically
Every clearance here is in the API, with alerts when new ones post.